This article is- freely available
- re-usable
Article
Soft Coral-Derived Lemnalol Alleviates Monosodium Urate-Induced Gouty Arthritis in Rats by Inhibiting Leukocyte Infiltration and iNOS, COX-2 and c-Fos Protein Expression
1
Department of Marine Biotechnology and Resources, Asia-Pacific Ocean Research Center, National Sun Yat-sen University, Kaohsiung 80424, Taiwan
2
Department of Orthopaedic Surgery, Ping-Tung Christian Hospital, 60, Ta-Lian Road, Ping-Tung 90059, Taiwan
3
Department of Fragrance and Cosmetic Science, Center of Excellence for Environmental Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
4
Department of Life Science, Institute of Molecular Biology, National Chung-Cheng University, Chia-Yi 62102, Taiwan
* Author to whom correspondence should be addressed.
Received: 28 November 2012; in revised form: 21 December 2012 / Accepted: 26 December 2012 / Published: 10 January 2013
Abstract: An acute gout attack manifests in the joint as dramatic inflammation. To date, the clinical use of medicinal agents has typically led to undesirable side effects. Numerous efforts have failed to create an effective and safe agent for the treatment of gout. Lemnalol — an extract from Formosan soft coral — has documented anti-inflammatory and anti-nociceptive properties. In the present study, we attempt to examine the therapeutic effects of lemnalol on intra-articular monosodium urate (MSU)-induced gouty arthritis in rats. In the present study, we found that treatment with lemnalol (intramuscular [im]), but not colchicine (oral [po]), significantly attenuated MUS-induced mechanical allodynia, paw edema and knee swelling. Histomorphometric and immunohistochemistry analysis revealed that MSU-induced inflammatory cell infiltration, as well as the elevated expression of c-Fos and pro-inflammatory proteins (inducible nitric oxide synthase and cyclooxygenase-2) observed in synovial tissue, were significantly inhibited by treatment with lemnalol. We conclude that lemnalol may be a promising candidate for the development of a new treatment for gout and other acute neutrophil-driven inflammatory diseases.
Keywords: gout; lemnalol; monosodium urate; allodynia; inflammation
Article Statistics
Click here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Lee, H.-P.; Huang, S.-Y.; Lin, Y.-Y.; Wang, H.-M.; Jean, Y.-H.; Wu, S.-F.; Duh, C.-Y.; Wen, Z.-H. Soft Coral-Derived Lemnalol Alleviates Monosodium Urate-Induced Gouty Arthritis in Rats by Inhibiting Leukocyte Infiltration and iNOS, COX-2 and c-Fos Protein Expression. Mar. Drugs 2013, 11, 99-113.
AMA Style
Lee H-P, Huang S-Y, Lin Y-Y, Wang H-M, Jean Y-H, Wu S-F, Duh C-Y, Wen Z-H. Soft Coral-Derived Lemnalol Alleviates Monosodium Urate-Induced Gouty Arthritis in Rats by Inhibiting Leukocyte Infiltration and iNOS, COX-2 and c-Fos Protein Expression. Marine Drugs. 2013; 11(1):99-113.
Chicago/Turabian Style
Lee, Hsin-Pai; Huang, Shi-Ying; Lin, Yen-You; Wang, Hui-Min; Jean, Yen-Hsuan; Wu, Shu-Fen; Duh, Chang-Yih; Wen, Zhi-Hong. 2013. "Soft Coral-Derived Lemnalol Alleviates Monosodium Urate-Induced Gouty Arthritis in Rats by Inhibiting Leukocyte Infiltration and iNOS, COX-2 and c-Fos Protein Expression." Mar. Drugs 11, no. 1: 99-113.